Alison Marker

1.6k citations

31 papers · 774 indexed · h-index 14

Impact in

Endocrinology, Diabetes and Metabolism top 5%
- Hormonal Regulation and Hypertension
- Adrenal Hormones and Disorders
Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism

Papers in ⓘ

Surgery 14
- Adrenal and Paraganglionic Tumors 7
Molecular Biology 8
- Metabolism, Diabetes, and Cancer 3
- Mitochondrial Function and Pathology 3

Co-authors: Lisa Happerfield (4 shared papers)Ann Colosia (4 shared papers)M. Raafat El‐Maghrabi (4 shared papers)S.J. Pilkis (4 shared papers)Elena Azizan (3 shared papers)Morris J. Brown (3 shared papers)Junhua Zhou (3 shared papers)J Pilkis (2 shared papers)
Journals: The Journal of Clinical Endocrinology & Metabolism (2 papers)Journal of Biological Chemistry (2 papers)Proceedings of the National Academy of Sciences (1 paper)Journal of Cellular Biochemistry (1 paper)Lara D. Veeken (1 paper)
Partner nations: United Kingdom United States Japan

In The Last Decade

Alison Marker

31 papers receiving 745 citations

Peers

Countries citing papers authored by Alison Marker

Since Specialization

Citations

This map shows the geographic impact of Alison Marker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Marker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Marker more than expected).

Fields of papers citing papers by Alison Marker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alison Marker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Marker. The network helps show where Alison Marker may publish in the future.

Co-authors

The 25 scholars most cited alongside Alison Marker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alison Marker Line = papers co-authored together Alison Marker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Microarray, qPCR, andKCNJ5Sequencing of Aldosterone-Producing Adenomas Reveal Differences in Genotype and Phenotype between Zona Glomerulosa- and Zona Fasciculata-Like Tumors The Journal of Clinical Endocrinology & Metabolism ·Elena Azizan, Brian Lam, Stephen Newhouse, Junhua Zhou, Rhoda E. Kuc, Jennifer Clarke, Lisa Happerfield, Alison Marker, Gary J. Hoffman, Morris J. Brown	2012	144
2	Pregnancy, Primary Aldosteronism, and AdrenalCTNNB1Mutations New England Journal of Medicine ·Ada Ee Der Teo, Sumedha Garg, Lalarukh Haris Shaikh, Junhua Zhou, Fiona E. Karet, Mark Gurnell, Lisa Happerfield, Alison Marker, Mariann Bienz, Elena Azizan, Morris J. Brown	2015	92
3	Induction of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase mRNA by refeeding and insulin. Journal of Biological Chemistry ·Ann Colosia, Alison Marker, Aksel Lange, M. Raafat El‐Maghrabi, D K Granner, Albert Tauler, J Pilkis, S.J. Pilkis	1988	88
4	cDNA sequence of rat liver fructose-1,6-bisphosphatase and evidence for down-regulation of its mRNA by insulin. Proceedings of the National Academy of Sciences ·M. Raafat El‐Maghrabi, J Pilkis, Alison Marker, Ann Colosia, Gisela D’Angelo, Blair A. Fraser, S.J. Pilkis	1988	63
5	Intestinal inflammation, ileal structure and function in HIV AIDS ·Ingvar Bjarnason, Dan R. Sharpstone, Nick Francis, Alison Marker, Chris Taylor, M C Barrett, Andrew J. Macpherson, Christine Baldwin, Ian S. Menzies, Roger C. Crane, Terry Smith, A. Pozniak, Brian Gazzard	1996	53
6	Deregulation of SYCP2 predicts early stage human papillomavirus‐positive oropharyngeal carcinoma: A prospective whole transcriptome analysis Cancer Science ·Liam Masterson, Frédéric Sorgeloos, David M. Winder, Matt Lechner, Alison Marker, Shalini Malhotra, Holger Sudhoff, Piyush Jani, Peter Goon, Jane Sterling	2015	42
7	A review of the tumour spectrum of germline succinate dehydrogenase gene mutations: Beyond phaeochromocytoma and paraganglioma Clinical Endocrinology ·James MacFarlane, Keat Cheah Seong, Chad Bisambar, Basetti Madhu, Kieren Allinson, Alison Marker, Anne Y. Warren, Soo‐Mi Park, Olivier Giger, Benjamin Challis, Eamonn R. Maher, Ruth Casey	2020	39
8	Squamous Cell Carcinoma of the Temporal Bone Otology & Neurotology ·Liam Masterson, Maral J. Rouhani, Neil Donnelly, James R. Tysome, Parag M. Patel, Sarah Jefferies, Tom Roques, Christopher Scrase, Richard Mannion, Robert Macfarlane, David G. Hardy, Amer Durrani, Richard D. Price, Alison Marker, Patrick Axon, David Moffat	2014	31
9	Translating In Vivo Metabolomic Analysis of Succinate Dehydrogenase–Deficient Tumors Into Clinical Utility JCO Precision Oncology ·Ruth Casey, Mary A. McLean, Basetti Madhu, Benjamin Challis, Rogier ten Hoopen, Thomas M. Roberts, Graeme R. Clark, Deborah Pitfield, Helen Simpson, V.R. Bulusu, Kieren Allinson, Lisa Happerfield, Soo‐Mi Park, Alison Marker, Olivier Giger, Eamonn R. Maher, Ferdia A. Gallagher	2018	29
10	Glucocorticoid Regulation of Hepatic 6-Phosphofructo-2-kinase/Fructose-2,6-bisphosphatase Gene Expression Journal of Biological Chemistry ·Alison Marker, Ann Colosia, Albert Tauler, David H. Solomon, Yvon E. Cayre, Aksel Lange, M. Raafat El‐Maghrabi, S.J. Pilkis	1989	28
11	Familial Adrenocortical Carcinoma in Association With Lynch Syndrome The Journal of Clinical Endocrinology & Metabolism ·Benjamin Challis, Narayanan Kandasamy, Andrew Powlson, Olympia Koulouri, Anand K. Annamalai, Lisa Happerfield, Alison Marker, Mark J. Arends, Serena Nik‐Zainal, Mark Gurnell	2016	26
12	Rapid disease progression in a patient with mismatch repair-deficient and cortisol secreting adrenocortical carcinoma treated with pembrolizumab Seminars in Oncology ·Ruth Casey, Olivier Giger, Ian Seetho, Alison Marker, Deborah Pitfield, Louise H. Boyle, Mark Gurnell, Ashley Shaw, Marc Tischkowitz, Eamonn R. Maher, Krishna Chatterjee, Tobias Janowitz, George Mells, Pippa Corrie, Benjamin Challis	2018	23
13	Sequence of the 5′-flanking region of the rat 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase gene: Regulation by glucocorticoids Biochemical and Biophysical Research Communications ·Aksel Lange, L Kümmel, M. Raafat El‐Maghrabi, Albert Tauler, Ann Colosia, Alison Marker, S.J. Pilkis	1989	21
14	Role of the adenylate cyclase, phosphoinositidase C and receptor tyrosyl kinase systems in the control of hepatocyte proliferation by hepatocyte growth factor Biochemical Pharmacology ·Alison Marker, Euan Galloway, S. Pamer, Toshikazu Nakamura, Gwyn W. Gould, R N MacSween, Mark Bushfield	1992	18
15	Investigating the role of human papillomavirus in squamous cell carcinoma of the temporal bone Liam Masterson, DM Winder, Alison Marker, JC Sterling, Holger Sudhoff, David Moffat, Pkc Goon	2013	13
16	A paediatric case of a solitary fibrous tumour of the parotid gland International Journal of Pediatric Otorhinolaryngology ·Michael P. Thompson, L. Cheng, James A. Stewart, Alison Marker, David M. Adlam	2004	11
17	[Mitochondrial antibodies in nonhepatic diseases. Occurrence, significance and differential diagnosis]. PubMed ·Berg Pa, U Traunecker, Alison Marker	1973	10
18	Regulation of hepatocyte adenylate cyclase by amylin and CGRP: A single receptor displaying apparent negative cooperativity towards CGRP and simple saturation kinetics for amylin, a requirement for phosphodiesterase inhibition to observe elevated hepatocyte cyclic AMP levels and the phosphorylation of Gi-2 Journal of Cellular Biochemistry ·Miles D. Houslay, Nicholas J. Morris, Anne Savage, Alison Marker, Mark Bushfield	1994	9
19	Inverted papilloma of lacrimal sac invading into the orbit: Case report and review of literature Journal of Cancer Research and Therapeutics ·RaghavC Dwivedi, AlistairW Hardy, Liam Masterson, Faruque Riffat, Alison Marker, SimonA Woodruff, Piyush Jani	2015	8
20	Behcet's syndrome progressing to gastrointestinal perforation in a West African male Lara D. Veeken ·C. Barr Taylor, Nadeen Low, Shashi Raj, C. G. Barnes, Alison Marker, Anthony du Vivier, A L Pozniak	1997	5

About Alison Marker

Alison Marker is a scholar working on Surgery, Molecular Biology, Endocrinology, Diabetes and Metabolism, Cancer Research and Oncology, having authored 31 papers that have together received 774 indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (7 papers), Adrenal and Paraganglionic Tumors (7 papers), Hormonal Regulation and Hypertension (4 papers), Metabolism, Diabetes, and Cancer (3 papers), Ear and Head Tumors (3 papers), Mitochondrial Function and Pathology (3 papers), Genetic factors in colorectal cancer (2 papers) and Vascular Tumors and Angiosarcomas (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (311 citations), Cancer Research (200 citations), Surgery (354 citations), Otorhinolaryngology (31 citations) and Virology (24 citations). Alison Marker has collaborated with scholars based in United Kingdom, United States and Japan. Frequent co-authors include Lisa Happerfield, Ann Colosia, M. Raafat El‐Maghrabi, S.J. Pilkis, Elena Azizan, Morris J. Brown, Junhua Zhou, J Pilkis, Albert Tauler and Aksel Lange. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, Journal of Cellular Biochemistry and Lara D. Veeken.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact